Windtree Therapeutics Inc
WINT- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0000946486
No open-market purchases or sales by Windtree Therapeutics Inc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q2 2022 vs. Q1 2022
How the institutions holding Windtree Therapeutics Inc changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 27 | 25 | −2 |
| Shares | 1.54M | 1.60M | +60.0K (+3.9%) |
| Value | $1.76M | $664.4K | −$1.09M (−62.2%) |
New holders (2)
Institutions that held Windtree Therapeutics Inc at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 15,286 | $6.00K | 0.00% |
| Urban Wealth Management, LLC | 4,087 | $2.00K | 0.01% |
Sold out (4)
Institutions that held Windtree Therapeutics Inc at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Kepos Capital LP | 165,000 | $188.0K |
| BlackRock Inc. | 48,660 | $56.0K |
| Federated Hermes, Inc. | 951 | $1.00K |
| Tradewinds Capital Management, LLC | 400 | $0 |